SCHEMBL7701752

SCHEMBL7701752

Oc1ccc(-c2cncc(C#CC3CCCN3)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 4/20 0.36
CDK5R1 Q15078 4/20 0.36
CHRNB4 P30926 1/20 0.34
CHRNA3 P32297 1/20 0.34
PRKCZ Q05513 1/20 0.34
PRKD2 Q9BZL6 1/20 0.34
USP7 Q93009 2/20 0.33
CLK2 P49760 1/20 0.33
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
HSD17B1 P14061 1/20 0.32
ESR2 Q92731 1/20 0.32
CHRNB2 P17787 2/20 0.32
CHRNA4 P43681 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7701750 1.00 CDK5 (0.36) CDK5CDK5R1CHRNB4CHRNA3PRKCZ
SCHEMBL5848974 0.87 CHRNB2 (0.42) CHRNB4CHRNA3CHRNB2CHRNA4
SCHEMBL5849392 0.87 CHRNB2 (0.42) CHRNB4CHRNA3CHRNB2CHRNA4
SCHEMBL5848969 0.87 CHRNB2 (0.42) CHRNB4CHRNA3CHRNB2CHRNA4
SCHEMBL7689822 0.84 GRM5 (0.47) CHRNB4CHRNA3CYP11B1CYP11B2CHRNB2
SCHEMBL7689824 0.84 GRM5 (0.47) CHRNB4CHRNA3CYP11B1CYP11B2CHRNB2
SCHEMBL5848829 0.82 LTA4H (0.42) CHRNB2CHRNA4
SCHEMBL5849286 0.82 CHRNB4 (0.39) CHRNB4CHRNA3CHRNB2CHRNA4
SCHEMBL5849278 0.82 CHRNB4 (0.39) CHRNB4CHRNA3CHRNB2CHRNA4
SCHEMBL5848891 0.76 CHRNA3 (0.43) CHRNB4CHRNA3CHRNB2CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002088114-A2 HETEROARYL OFEFINIC AZACYCLIC AND HETEROARYL ACETYLENIC AZACYCLIC COMPOUNDS FOR THE TREATMENT OF CNS DISORDERS TARGACEPT, INC. (US) 2002-11-07 WO claimed